Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Travera Inc
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
Centre Oscar Lambret
SWOG Cancer Research Network